These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19349078)

  • 21. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clomipramine in the treatment of agoraphobic inpatients resistant to behavioral therapy.
    Hoffart A; Due-Madsen J; Lande B; Gude T; Bille H; Torgersen S
    J Clin Psychiatry; 1993 Dec; 54(12):481-7. PubMed ID: 8276739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind, comparative study of dothiepin and clomipramine in the treatment of major depressive illness.
    Welch CP; Tweed JA; Smithers A; Gostick NK; Raniwalla J
    Int J Clin Pract; 1997 Sep; 51(6):360-3. PubMed ID: 9489063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clomipramine in obsessive-compulsive disorder: clinical response and plasma levels.
    Mavissakalian MR; Jones B; Olson S; Perel JM
    J Clin Psychopharmacol; 1990 Aug; 10(4):261-8. PubMed ID: 2286699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.
    Petracca G; Tesón A; Chemerinski E; Leiguarda R; Starkstein SE
    J Neuropsychiatry Clin Neurosci; 1996; 8(3):270-5. PubMed ID: 8854297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of clomipramine and desmethylclomipramine and clinical improvement in panic disorder.
    Marcourakis T; Gorenstein C; Ramos RT; da Motta Singer J
    J Psychopharmacol; 1999; 13(1):40-4. PubMed ID: 10221358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder.
    Sasson Y; Iancu I; Fux M; Taub M; Dannon PN; Zohar J
    Eur Neuropsychopharmacol; 1999 Mar; 9(3):191-6. PubMed ID: 10208287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Opipramol in anxiety and somatoform disorders. Results of a controlled study].
    Volz HP; Möller HJ
    Fortschr Neurol Psychiatr; 1998 Dec; 66 Suppl 1():S21-4. PubMed ID: 9922923
    [No Abstract]   [Full Text] [Related]  

  • 31. The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine.
    Bech P; Stage KB; Larsen JK; Vestergaard P; Gram LF;
    J Affect Disord; 2012 Nov; 140(3):253-9. PubMed ID: 22381949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study.
    Remington G; Sloman L; Konstantareas M; Parker K; Gow R
    J Clin Psychopharmacol; 2001 Aug; 21(4):440-4. PubMed ID: 11476129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dose-finding and discontinuation study of clomipramine in panic disorder.
    Lotufo-Neto F; Bernik M; Ramos RT; Andrade L; Gorenstein C; Cordas T; Melo M; Gentil V
    J Psychopharmacol; 2001 Mar; 15(1):13-7. PubMed ID: 11277602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes.
    Eberhard G; von Knorring L; Nilsson HL; Sundequist U; Björling G; Linder H; Svärd KO; Tysk L
    Neuropsychobiology; 1988; 19(1):25-34. PubMed ID: 3054623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind trial of amineptine and clomipramine in the treatment of depression.
    Lemoine P; Achaintre A; Balvay G; Bonnet H; Burgat R; Carrier C; Perrin J
    Curr Med Res Opin; 1981; 7(4):234-40. PubMed ID: 7014104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discomfort or disability in patients with chronic pain syndrome.
    Poulsen DL; Hansen HJ; Langemark M; Olesen J; Bech P
    Psychother Psychosom; 1987; 48(1-4):60-2. PubMed ID: 3333290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Gelsemium 5CH and 15CH on anticipatory anxiety: a phase III, single-centre, randomized, placebo-controlled study.
    Paris A; Schmidlin S; Mouret S; Hodaj E; Marijnen P; Boujedaini N; Polosan M; Cracowski JL
    Fundam Clin Pharmacol; 2012 Dec; 26(6):751-60. PubMed ID: 21954883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain.
    Atkinson HJ; Slater MA; Williams RA; Zisook S; Patterson TL; Grant I; Wahlgren DR; Abramson I; Garfin SR
    Pain; 1998 Jun; 76(3):287-296. PubMed ID: 9718247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study.
    Loldrup D; Langemark M; Hansen HJ; Olesen J; Bech P
    Psychopharmacology (Berl); 1989; 99(1):1-7. PubMed ID: 2506594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The treatment of chronic pain symptoms with psychotropic drugs (author's transl)].
    Kocher R
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Nov; 9(6):337-41. PubMed ID: 64986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.